gemcitabine has been researched along with Cholecystitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Du, Z; Feng, R; Li, R; Qi, L; Ye, J; Yu, L; Zhai, W | 1 |
| Arizumi, T; Hirano, K; Isayama, H; Ito, Y; Kawabe, T; Kogure, H; Matsubara, S; Nakai, Y; Omata, M; Sasahira, N; Sasaki, T; Tada, M; Togawa, O; Tsujino, T; Yagioka, H; Yoshida, H | 1 |
2 other study(ies) available for gemcitabine and Cholecystitis
| Article | Year |
|---|---|
Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Calreticulin; Cell Line, Tumor; Cholecystitis; Deoxycytidine; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Oncogenes; Prognosis; Random Allocation; Xenograft Model Antitumor Assays | 2021 |
Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biliary Tract Surgical Procedures; Cholangitis; Cholecystitis; Cholestasis; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Neutropenia; Palliative Care; Pancreatic Neoplasms; Prosthesis Design; Prosthesis-Related Infections; Retrospective Studies; Stents; Time Factors; Treatment Outcome | 2008 |